A Pilot Study of the Effect of Individualized Clinical Management Among

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04559633` - Cognitive and Behavioral Therapy in School Refusal	N/A
Not yet recruiting	`NCT05104112` - Evaluation of a Therapeutic Education Program for Pregnant Women With a First Child Diagnosed With an Autism Spectrum Disorder	N/A
Recruiting	`NCT05690113` - Translation and Validation of the "Children and Adolescent Trauma Screen" in French

See also

Status

Clinical Trial

Phase

Recruiting

NCT04559633 - Cognitive and Behavioral Therapy in School Refusal

N/A

Not yet recruiting

NCT05104112 - Evaluation of a Therapeutic Education Program for Pregnant Women With a First Child Diagnosed With an Autism Spectrum Disorder

N/A

Recruiting

NCT05690113 - Translation and Validation of the "Children and Adolescent Trauma Screen" in French

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03694184
Study type	Observational
Source	Centre Hospitalier Universitaire de Besancon
Contact	Lauriane Vulliez, MD
Phone	0033381218391
Email	lvulliez@chu-besancon.fr
Status	Recruiting
Phase
Start date	July 1, 2018
Completion date	July 2019

A Pilot Study of the Effect of Individualized Clinical Management Among Parent/Child Dyads on Continuity of Care and Interaction — Rétro-GUIDANCE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms